Health breakthroughs and money matters, in plain words

Home » Enoki Mushrooms and Cancer: What Mouse Studies and Nagano Data Really Show

Enoki Mushrooms and Cancer: What Mouse Studies and Nagano Data Really Show

By

–

Enoki Mushrooms and Cancer: What Mouse Studies and Nagano Data Really Show

An October 2026 Instagram reel claimed that boiling supermarket enoki mushrooms in water made tumours vanish. It raised a fair question: can the common fungus fight cancer?

Background

Interest in enoki mushrooms and cancer is not new. In the 1980s, researchers in Japan and Korea began investigating the fungus Flammulina velutipes, the species sold as enoki, for its biological activity. A 1985 Japanese study isolated a glycoprotein called proflamin from the mushroom’s culture mycelium. When given orally to mice at 10 mg/kg, proflamin increased median survival time by 86 percent in mice with B-16 melanoma and by 84 percent in mice with adenocarcinoma 755. Critically, the study found that proflamin had no cytocidal effect on cultured cell lines in vitro, meaning it did not directly kill cancer cells in a petri dish. Instead, the researchers concluded the compound acts by modulating the immune system.

Around the same period, a Korean study examined a protein-bound polysaccharide fraction from enoki mushrooms and tested it against Sarcoma 180 in mice. At a dose of 10 mg/kg per day for ten days, the fraction inhibited tumor growth by 62.3 percent, and three of the ten treated mice experienced complete tumor regression.

In 1989, Dr. Tetsuro Ikekawa, then an epidemiologist at the National Cancer Center in Tokyo, published a study examining cancer death rates in Nagano Prefecture. Nagano was the center of enoki mushroom cultivation in Japan. Dr. Ikekawa compared cancer death rates between the general population and families of enoki growers. The general population had a cancer death rate of 160 per 100,000. Among enoki growers’ families, the rate dropped to 97 per 100,000. Men in the group saw a 36.6 percent decrease in cancer deaths; women saw a 42.7 percent decrease. The study population was approximately 175,000 people and was age-adjusted. It compared groups; it was not a trial.

How it works

The biological mechanisms identified in the laboratory do not translate directly to the dinner plate. The 1985 study on proflamin showed that the compound extended survival in mice with established tumors, but it did not shrink tumors directly. The effect appeared to be immune-mediated. Similarly, the 1983 research on a polysaccharide called EA6 found that its antitumor effect was dependent on dose, timing, and frequency of administration combined with a vaccine. When given after vaccination, EA6 prolonged survival by 223 percent in a leukemia challenge model. The specific immunity induced by the vaccine was not affected by the polysaccharide.

Test-tube studies from more recent years support the idea that enoki compounds can affect cancer cell lines. A 2013 test-tube study suggested enoki extract blocked the growth of liver cancer cells, and a 2015 study found that eight medicinal mushroom extracts, including enoki, may have decreased the growth of breast and cervical cancer cells. A 2012 test-tube study reported that compounds from enoki suppressed the growth of stomach cancer cells by up to 95 percent. However, the Healthline review of enoki benefits notes that these test-tube studies used highly concentrated extracts that are not achievable through normal dietary consumption.

The numbers

The 1989 Nagano study remains the primary human-scale data point. It reported a correlation between higher enoki consumption and lower cancer mortality in a specific population, but it did not establish causation. The study observed that enoki farmers and their families consumed significantly more mushrooms than the general public, but it did not control for other dietary or lifestyle factors. In mouse studies, the observed survival increases and tumor inhibition ratios were achieved with purified protein fractions or polysaccharides, not with whole mushrooms eaten as food. A 2014 animal study found that hamsters consuming enoki mushroom powder had lower levels of triglycerides and LDL cholesterol, but the study did not measure tumor regression at food-relevant doses.

What it means now

The viral claim that boiled enoki mushrooms make tumors vanish is not supported by the available evidence. The mouse studies used purified extracts, and the Nagano data showed an association, not a proven effect. Eating enoki mushrooms as part of a balanced diet provides nutrients such as fiber, B vitamins, and antioxidants, which support general health, but the current research does not demonstrate that enoki mushrooms cure or prevent cancer in humans. Anyone considering dietary changes during cancer treatment should consult their doctor or oncologist.

Safety and Toxicity Considerations

Animal experiments suggest that the bioactive fractions derived from enoki mushrooms are well‑tolerated at the doses used for antitumor testing. The 1985 proflamin study reported that oral administration of the purified glycoprotein to mice produced “no lethal or any other apparent adverse effect”. Likewise, the Korean researchers who isolated a protein‑bound polysaccharide fraction explicitly sought “components with low toxicity” and observed no overt toxicity in the treated mice. These findings indicate that, at least in short‑term rodent models, the isolated extracts do not cause obvious harm.

However, the safety data are limited to purified compounds given by gavage or intraperitoneal injection, not to whole enoki mushrooms consumed as food. No human clinical trials have evaluated adverse events, dosing thresholds, or potential interactions with cancer therapies. Consequently, extrapolating the animal tolerability to everyday dietary intake remains speculative. Healthline’s review notes that the test-tube studies used highly concentrated extracts, far beyond what a normal serving of enoki provides.

Sources

Photo: Fumikas Sagisavas (CC0)

Get breaking stories first on our Telegram channel.

More stories by

Most read

Health & Medicine

Personal Finance

Cancer News

Health News